Bayer adopted Genpact's PVAI suite to automate adverse event extraction and case management.
Bayer wanted to process safety data faster and spot drug-associated side effects earlier. Genpact deployed its PVAI machine-learning suite and Cora PharmacoVigilance software on Bayer's existing systems, with Bayer going live with the AI-based case management module. The release gives no quantified results.
Genpact is a global professional services firm, used by pharma for pharmacovigilance AI, regulatory affairs support, compliance and intelligent operations
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Genpact on its own site — read the original case study on biospace.com ↗
Note: Partnership press release; no figures.
Related use cases
- 01A consumer health company used Genpact's generative AI to cut regulatory intelligence reporting from weeks to hours.
- 02Genpact ran CMC lifecycle regulatory support for a major pharma to free staff and speed submissions.
- 03Transforming Content Operations for 2x Faster Time to Market
- 04Astellas: Breaking Access Barriers with Veeva Compliant Chat
- 05How Pacira Generated Deep Website Insights to Get Patients on Therapy Faster
- 06Reaching Underserved Communities with Smarter Targeting